PEG-BIO Biopharm Co.,Ltd(chongqing).
Core Technology
6.The homologous tetramer of pegylated thrombogenin mimicking peptide and its application
Source: | Author:pro954f45 | Published time: 2018-10-17 | 209 Views | Share:
    The present invention relates to a method for preparing a homologous tetramer of a pegylated thrombogenin analogue peptide with a long-term effect and its application. Through amino terminal for cysteine residues of platelet peptide hormone analog dimers with polyethylene glycol (peg) molecules on both ends of coupling of polyethylene glycol (peg) and platelet peptide hormone analog autotetraploid polymers, have long-term rise in the number of peripheral blood platelet function, can be used as a treatment of thrombocytopenia, including caused by chemotherapy of idiopathic thrombocytopenic purpura, thrombocytopenia, hepatitis syndrome caused by thrombocytopenia and myelodysplastic syndrome, etc.